RxDoctor Payments DataLook up a doctor →

Stephen Divers, MD

Hematology & Oncology · Hot Springs, ARNPI 1760469407

Payments from drug & device makers

$596,546in general payments, 2019–2025

Across 1,119 payments — averaging $533.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$198K
  • Astrazeneca UK Limited$166K
  • Genentech, Inc.$91K
  • Eli Lilly$70K
  • Bristol Myers Squibb$23K
  • Daiichi Sankyo Inc.$15K
  • plus $33K from 54 others
$16,150in research payments, 2019–2025

Across 2 payments — averaging $8075.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$16K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)96$198,056
Astrazeneca UK Limited8$166,343
Genentech, Inc.35$91,223
Eli Lilly7$69,549
Bristol Myers Squibb58$22,637
Daiichi Sankyo Inc.37$14,965
Pharmacosmos Therapeutics Inc.35$11,166
Janssen Scientific Affairs, LLC4$1,935
Amgen29$1,855
Johnson & Johnson(2 entities)44$1,479
Spectrum Pharmaceuticals Inc.6$1,383
Novartis88$1,252
Beigene USA, Inc.16$1,145
Merck61$1,010
Avyxa Pharma, LLC1$1,000
Pfizer66$901
Eisai Inc.26$708
GSK38$679
EMD Serono, Inc.9$635
AbbVie22$469
Incyte Corporation23$465
Lilly USA, LLC28$453
Sanofi23$442
E.r. Squibb & Sons, L.L.C.31$424
Gilead(2 entities)24$398
Bayer18$345
Astellas Pharma US Inc21$331
Exelixis Inc.19$314
Genentech USA, Inc.23$310
ASD Specialty Healthcare, LLC2$308
Seagen Inc.18$303
Karyopharm Therapeutics Inc.13$222
Takeda Pharmaceuticals U.S.A., Inc.10$217
Rigel Pharmaceuticals, Inc.12$195
Sumitomo Pharma America, Inc.8$194
Array Biopharma Inc10$193
Morphosys, US Inc.10$193
Boehringer Ingelheim9$190
Puma Biotechnology, Inc.7$186
Servier Pharmaceuticals LLC2$186
Pharmacyclics LLC, An Abbvie Company11$182
Regeneron Healthcare Solutions, Inc.6$138
Beone Medicines USA, Inc.6$132
ADC Therapeutics America, Inc.7$124
Myovant Sciences Inc.7$112
Ipsen Biopharmaceuticals, Inc6$104
Adaptive Biotechnologies Corporation2$94
Sobi, Inc5$90
Epizyme, Inc.6$90
Fennec Pharmaceuticals, Inc.1$82
Blueprint Medicines Corporation3$62
Genmab U.S., Inc.4$58
Iovance Biotherapeutics, Inc.2$54
Dendreon Pharmaceuticals LLC2$51
Springworks Therapeutics, Inc.2$51
Deciphera Pharmaceuticals Inc.3$47
Clovis Oncology, Inc.3$47
Mirati Therapeutics, Inc.3$47
Stemline Therapeutics Inc.3$45
AMAG Pharmaceuticals, Inc.2$39

How this compares

$596,546 in reported general payments places this provider in the 85th percentile of 92 hematology & oncology providers in Arkansas.

See all hematology & oncology providers in Arkansas →

Medicare billing

Part B allowed, 2024
$11,026,220
Medicare patients
1,434
Services billed
492,745

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Hot Springs

See the full list for Arkansas →

Where these figures come from

Is this you, or does something look wrong? →